Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis

Fig. 2

Summary of the secondary efficacy outcomes. Network plot of (A) The forest plot for 50% response rates; (B) The SUCRA value of each treatment for 50% response rates. (C) The forest plot for 75% response rates; (D) The SUCRA value of each treatment for 75% response rates. SUCRA: surface under the cumulative ranking curve

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us